JPS6097918A - インタ−フエロン持続性製剤 - Google Patents

インタ−フエロン持続性製剤

Info

Publication number
JPS6097918A
JPS6097918A JP58206226A JP20622683A JPS6097918A JP S6097918 A JPS6097918 A JP S6097918A JP 58206226 A JP58206226 A JP 58206226A JP 20622683 A JP20622683 A JP 20622683A JP S6097918 A JPS6097918 A JP S6097918A
Authority
JP
Japan
Prior art keywords
interferon
collagen
long
carrier
acting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58206226A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0372046B2 (enrdf_load_stackoverflow
Inventor
Yoshinari Yamahira
山平　良也
Takaharu Fujioka
藤岡　敬治
Shigeji Sato
重二 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP58206226A priority Critical patent/JPS6097918A/ja
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to EP19840112310 priority patent/EP0139286B1/en
Priority to DE8484112313T priority patent/DE3484584D1/de
Priority to EP19840112313 priority patent/EP0140255B1/en
Priority to DE8484112310T priority patent/DE3484951D1/de
Priority to DE19843486029 priority patent/DE3486029T2/de
Priority to EP19840112312 priority patent/EP0138216B1/en
Publication of JPS6097918A publication Critical patent/JPS6097918A/ja
Priority to US06/846,193 priority patent/US4774091A/en
Priority to US06/855,387 priority patent/US4855134A/en
Priority to US07/187,443 priority patent/US5021241A/en
Priority to US07/358,157 priority patent/US5081156A/en
Publication of JPH0372046B2 publication Critical patent/JPH0372046B2/ja
Priority to US07/844,929 priority patent/US5385738A/en
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP58206226A 1983-10-14 1983-11-01 インタ−フエロン持続性製剤 Granted JPS6097918A (ja)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP58206226A JPS6097918A (ja) 1983-11-01 1983-11-01 インタ−フエロン持続性製剤
EP19840112310 EP0139286B1 (en) 1983-10-14 1984-10-12 Prolonged sustained-release preparations
DE8484112313T DE3484584D1 (de) 1983-10-14 1984-10-12 Injektionen mit verzoegerter abgabe.
EP19840112313 EP0140255B1 (en) 1983-10-14 1984-10-12 Sustained-release injections
DE8484112310T DE3484951D1 (de) 1983-10-14 1984-10-12 Verlaengerte praeparate mit verzoegerter abgabe.
DE19843486029 DE3486029T2 (de) 1983-10-14 1984-10-12 Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung.
EP19840112312 EP0138216B1 (en) 1983-10-14 1984-10-12 Sustained-release ifn preparation for parenteral administration
US06/846,193 US4774091A (en) 1983-10-14 1986-03-31 Long-term sustained-release preparation
US06/855,387 US4855134A (en) 1983-10-14 1986-04-24 Sustained-release preparation
US07/187,443 US5021241A (en) 1983-10-14 1988-04-28 Long-term sustained-release preparation
US07/358,157 US5081156A (en) 1983-10-14 1989-05-30 Sustained-release preparation
US07/844,929 US5385738A (en) 1983-10-14 1992-03-04 Sustained-release injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58206226A JPS6097918A (ja) 1983-11-01 1983-11-01 インタ−フエロン持続性製剤

Publications (2)

Publication Number Publication Date
JPS6097918A true JPS6097918A (ja) 1985-05-31
JPH0372046B2 JPH0372046B2 (enrdf_load_stackoverflow) 1991-11-15

Family

ID=16519848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58206226A Granted JPS6097918A (ja) 1983-10-14 1983-11-01 インタ−フエロン持続性製剤

Country Status (1)

Country Link
JP (1) JPS6097918A (enrdf_load_stackoverflow)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60174726A (ja) * 1984-02-21 1985-09-09 Nippon Shinyaku Co Ltd 注射用医薬組成物
JPS6363624A (ja) * 1986-09-04 1988-03-22 Etsuko Kakizaki 徐放性注射剤
JPH03505873A (ja) * 1988-06-17 1991-12-19 ナーチャー・インコーポレィテッド タイムリリースタンパク質
US5496559A (en) * 1991-04-08 1996-03-05 Sumitomo Pharmaceuticals Company, Limited Porous solid formulations containing proteinaceous physiologically active substances
US5922356A (en) * 1996-10-09 1999-07-13 Sumitomo Pharmaceuticals Company, Limited Sustained release formulation
JP2001199879A (ja) * 1999-11-10 2001-07-24 Sumitomo Pharmaceut Co Ltd 薬物放出製剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57150609A (en) * 1981-02-16 1982-09-17 Ici Ltd Pharmaceutical composition, heterogeneous copolymer comprising lactic acid and glycolic acid units and manufacture
JPS59501747A (ja) * 1982-09-29 1984-10-18 スピ−ルバ−グ　セオドア−　イ− カプセル封入された、治療物質産生性の遺伝子操作された生物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57150609A (en) * 1981-02-16 1982-09-17 Ici Ltd Pharmaceutical composition, heterogeneous copolymer comprising lactic acid and glycolic acid units and manufacture
JPS59501747A (ja) * 1982-09-29 1984-10-18 スピ−ルバ−グ　セオドア−　イ− カプセル封入された、治療物質産生性の遺伝子操作された生物

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60174726A (ja) * 1984-02-21 1985-09-09 Nippon Shinyaku Co Ltd 注射用医薬組成物
JPS6363624A (ja) * 1986-09-04 1988-03-22 Etsuko Kakizaki 徐放性注射剤
JPH03505873A (ja) * 1988-06-17 1991-12-19 ナーチャー・インコーポレィテッド タイムリリースタンパク質
US5496559A (en) * 1991-04-08 1996-03-05 Sumitomo Pharmaceuticals Company, Limited Porous solid formulations containing proteinaceous physiologically active substances
US5922356A (en) * 1996-10-09 1999-07-13 Sumitomo Pharmaceuticals Company, Limited Sustained release formulation
JP2001199879A (ja) * 1999-11-10 2001-07-24 Sumitomo Pharmaceut Co Ltd 薬物放出製剤

Also Published As

Publication number Publication date
JPH0372046B2 (enrdf_load_stackoverflow) 1991-11-15

Similar Documents

Publication Publication Date Title
KR100236771B1 (ko) 히아루론산을 이용한 약물의 서방성 미세입자 제형
US4855134A (en) Sustained-release preparation
CA2433037C (en) Sustained-release preparation
US6399103B1 (en) Method of producing a sustained-release preparation
ES2200375T3 (es) Metodos para fabricar preparaciones de liberacion controlada basadas en polimero.
FI96278B (fi) Menetelmä mikrokapselin valmistamiseksi, josta vapautuu pidennetysti luteinisoivaa hormonia vapauttavaa hormonia
EP0138216B1 (en) Sustained-release ifn preparation for parenteral administration
JP5160005B2 (ja) 徐放性製剤
US20090142399A1 (en) Dispersant agent for sustained-release preparations
JP2000516839A (ja) 皮下注入用、あるいは皮内注入用インプラント
JP2008528698A (ja) 埋め込み可能なインターフェロン含有デバイス
KR20010012374A (ko) 지속 효과를 갖는 서방성 겔
JP4683319B2 (ja) 徐放性製剤用の分散剤
JPH03163032A (ja) 脳内投与用徐放性製剤
JPS62230729A (ja) Ｃｓｆ徐放性製剤
JPS6097918A (ja) インタ−フエロン持続性製剤
JPH1045616A (ja) 注射用徐放性製剤
JPS61236729A (ja) 徐放性製剤
KR20050072094A (ko) 테모졸로마이드 함유 제어방출 시스템
JPH0512328B2 (enrdf_load_stackoverflow)
JPH08225454A (ja) マイクロスフェア製剤
JP2020531571A (ja) 超圧縮医薬製剤
US6723347B1 (en) Proces for producing protein powder
JPS60126217A (ja) 長期徐放性製剤
JP2837675B2 (ja) 徐放性微粒製剤